MS in the Media - 27 November 2020
21-27 November 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Depression affects ability to multitask
People with MS who have mild to moderate depression find it harder to do several things at once than depressed people who don't have MS, according to US research. The impact of depression on cognition may be the cause
Source: MS News Today
MS Trust link: Thinking and memory problems
Benefits process in Scotland altered
Benefit claims in Scotland are being made less traumatic, the Scottish government has announced. Claims will mostly be assessed on information from the applications process including from health care providers. The process will not be run by a private contractor.
Source: Scottish Government
MS Trust link: Benefits
Cancer risks assessed for people with MS
People with MS have the same risk of breast and colorectal cancer as the general population, but have a higher risk of urinary cancer, according to a Canadian study. The risk of ovarian cancer was also higher in MS and cervical and uterine cancers lower
Source: MedPage Today
MS Trust link: Comorbidities
Gut immune cells may calm relapses
Immune cells from the gut move to the brain during MS relapses and seem to have a role in calming down inflammation, according to an international research study.
Source: National MS Society (USA)
MS Trust link: MS research updates
Getting through homeschooling with MS
20 Jan 2021 - 00:00
In her latest blog for the MS Trust, Carla King looks at how to cope with homeschooling when you have MS.
MS in the Media
15 Jan 2021 - 00:00
- Covid vaccine advice for people with MS
- Potential MS vaccine in early trials
- Long-term benefits of DMDs studied
- Sunlight exposure and MS
Researchers develop mRNA vaccine to treat MS-like condition in mice
14 Jan 2021 - 00:00
A potential treatment for multiple sclerosis uses mRNA technology, similar to two of the Covid-19 vaccines. Find out more about this research.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
